1. Home
  2. PBT vs IVA Comparison

PBT vs IVA Comparison

Compare PBT & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Permian Basin Royalty Trust

PBT

Permian Basin Royalty Trust

HOLD

Current Price

$17.26

Market Cap

920.1M

Sector

Energy

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.46

Market Cap

769.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBT
IVA
Founded
1980
2011
Country
United States
France
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
920.1M
769.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PBT
IVA
Price
$17.26
$4.46
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$17.14
AVG Volume (30 Days)
87.7K
182.3K
Earning Date
01-01-0001
09-29-2025
Dividend Yield
1.88%
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$17,266,423.00
$19,929,536.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$53.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.01
$2.11
52 Week High
$20.46
$7.98

Technical Indicators

Market Signals
Indicator
PBT
IVA
Relative Strength Index (RSI) 38.68 52.12
Support Level $17.13 $4.05
Resistance Level $18.73 $4.61
Average True Range (ATR) 0.77 0.20
MACD -0.12 0.06
Stochastic Oscillator 9.39 73.85

Price Performance

Historical Comparison
PBT
IVA

About PBT Permian Basin Royalty Trust

Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: